JBC Invitrogen Ultrasensitive Cytokine Assays

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M201976200 on July 31, 2002

J. Biol. Chem., Vol. 277, Issue 39, 36174-36180, September 27, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/39/36174    most recent
M201976200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hossain, S.
Right arrow Articles by Lue, N. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hossain, S.
Right arrow Articles by Lue, N. F.

Functional Analysis of the C-terminal Extension of Telomerase Reverse Transcriptase

A PUTATIVE "THUMB" DOMAIN*

Shabbir Hossain, Sunitha Singh, and Neal F. LueDagger

From the Department of Microbiology and Immunology, William Randolph Hearst Microbiology Research Center, Weill Medical College of Cornell University, New York, New York 10021

Received for publication, February 27, 2002, and in revised form, July 3, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Telomerase is an RNA-protein complex responsible for the extension of one strand of telomere terminal repeats. The catalytic protein subunit of telomerase, known generically as telomerase reverse transcriptase (TERT), exhibits significant homology to reverse transcriptases (RTs) encoded by retroviruses and retroelements. The mechanisms of telomerase may therefore be similar to those of the conventional reverse transcriptases. In this report, we explore potential similarity between these two classes of proteins in a region with no evident sequence similarity. Previous analysis has implicated a C-terminal domain of retroviral RTs (known as the "thumb" domain) in template-primer binding and in processivity control. The equivalent region of TERTs, although similar to one another, does not exhibit significant sequence homology to retroviral RTs. However, we found that removal of this region of yeast TERT similarly resulted in a decrease in the stability of telomerase-DNA complex and in the processivity of telomerase-mediated nucleotide addition. Moreover, the C-terminal domain of TERT exhibits a nucleic acid binding activity when recombinantly expressed and purified. Finally, amino acid substitutions of conserved residues in this region of TERT were found to impair telomerase activity and processivity. We suggest that mechanistic similarity between telomerase and retroviral RTs may extend beyond the regions with apparent sequence similarity.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Telomerase is a ribonucleoprotein that is responsible for maintaining the terminal repeats of telomeres in most organisms (1). It acts as an unusual reverse transcriptase (RT),1 using a small segment of an integral RNA component as template for the synthesis of the dGT-rich strand of telomeres (2).

Telomerase activity has been characterized from a wide range of organisms and genes encoding both the RNA and protein components of the enzyme complex identified (for reviews see (3, 4)). Telomerase RNAs found in ciliated protozoa, in addition to having a short templating region, share a common secondary structure. Telomerase RNAs from yeast and mammals are considerably larger, and within each group conserved structural elements can be identified based on phylogenetic and mutational analysis (5, 6). The catalytic reverse transcriptase protein subunit (TERT), first purified from Euplotes aediculatus as p123, was found to be homologous to Est2p, a yeast protein required for telomere maintenance (7-9). Both proteins possess RT-like motifs, alterations therein can cause inactivation of telomerase activity and reduction in telomere lengths. Subsequently, homologs of TERT were identified in Schizosaccharomyces pombe, human, mouse, Tetrahymena, Oxytricha, and Arabidopsis (10-17). Because co-expression of TERT and telomerase RNA in vitro in the rabbit reticulocyte lysate system suffices to reconstitute enzyme activity (18, 19), these two subunits probably constitute the core of the enzyme complex. Several telomerase-associated polypeptides have been identified using either biochemical or genetic tools. Preliminary studies suggest that these factors may participate in telomerase assembly, function, or regulation (20-24).

Extensive mutational analysis of TERT residues equivalent to those located within functional motifs of conventional RTs supports an overall conservation of basic catalytic mechanisms between these two classes of enzymes. For example, the TERT analogues of RT residues essential for catalysis are absolutely required for telomerase activity and telomere maintenance (9, 18, 25-27). Conserved residues shown previously to modulate RT processivity have been found to be important determinants of telomerase processivity as well (28-30). In addition, the same tyrosine residue in conserved motif A allows both TERT and RTs to discriminate against incorporating ribonucleotides (31). However, some other crucial RT residues (e.g. a Gln in motif B') appear to be less important or even dispensable for telomerase function (9). Together, these results suggest that despite the high degree of sequence divergence (<20% sequence identity), TERT and conventional RTs may possess very similar polymerization mechanisms.

In retroviral RTs, the region immediately C-terminal to the RT motifs (known as the "thumb" domain) has been shown to be important in template/primer binding and in processive nucleotide addition. Such functions are readily comprehended in light of the structural disposition of the thumb domain, which comprises a bundle of three alpha -helices, part of which makes direct contact with the template/primer duplex (32). The comparable region of TERTs (henceforth referred to as the CTE for C-terminal extension) exhibits no evident sequence homology to retroviral RTs. However, previous work from our laboratory indicates that the CTE of yeast TERT (Est2p) is also required for optimal enzyme processivity, raising the possibility that the CTE may also constitute a thumb for telomerase. In this report, we explored the mechanistic basis for the function of telomerase CTE and found that it enhances the stability of telomerase-DNA interaction both before and after polymerization. The CTE of Est2p also possesses a nucleic acid binding activity when recombinantly expressed and purified. Finally, the CTEs of TERTs as a group appear to exhibit a low level of sequence conservation, and substitution of quite a few conserved CTE residues in Est2p was found to impair telomerase activity and processivity. Taken together, our study supports the notion that the CTE of TERT has a conserved function in promoting primer binding and telomerase processivity and that mechanistic similarity between telomerase and conventional RTs may be greater than indicated by apparent sequence similarity.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Yeast Strains, Plasmids, and Primer DNA-- The construction of a Delta est2 strain harboring the pSE-Est2-C874 plasmid (containing a protein A-tagged EST2 gene) has been described (33). This fully functional Est2p is designated as wild type telomerase throughout the text. The construction of the protein A-tagged C745 mutant has been described also (29). All substitution mutations in the CTE of EST2 were generated using the QuikChange protocol (Stratagene), appropriate primer oligonucleotides, and pSE-Est2-C874 as template. All point mutations were confirmed by sequencing. The oligodeoxynucleotide primers used for telomerase assays were purchased from Sigma and purified by denaturing gel electrophoresis prior to use. The primers have the following sequences: TEL15(m12), TGTCTGGTGTGTGGG; TEL24, TGTGTGGGTGTGTGGGTGTGTGGG; TEL66, TAGGGTAGTAGTAGGG.

Purification of and Assay for Yeast Telomerase-- Whole cell extracts and IgG-Sepharose-purified telomerase were prepared as described previously (29, 33-35). Each primer extension assay was carried out using 20 µl of IgG-Sepharose pretreated with 4 mg of protein extract and was initiated by the addition of a 15-µl mixture containing 100 mM Tris·HCl, pH 8.0, 4 mM magnesium chloride, 2 mM dithiothreitol, 2 mM spermidine, primer oligodeoxynucleotides, and varying combinations of labeled and unlabeled dGTP and dTTP. Primer extension products were processed and analyzed by gel electrophoresis as described previously (35, 36).

For the primer challenge experiment, the IgG-Sepharose-bound telomerase was preincubated with 40 ng of TEL15(m12) primer at room temperature for 15 min and then challenged with 400 ng of TEL24 primer. After 5, 15, and 40 min, labeled nucleotides (dTTP, 25 µCi) were added to initiate the polymerization reaction. For the measurement of enzyme-product stability, reactions were performed as described previously. Upon termination, the IgG-Sepharose was washed three times with 100 µl each of TMG-10 (150) buffer. The washes were pooled, digested with proteinase K, and extracted with phenol/chloroform/Isoamyl alcohol, and then the free products were precipitated and analyzed along with the enzyme-bound products.

For kinetic analysis, primer extension assays were performed using IgG-Sepharose-purified enzyme, varying concentrations of a 15-nt primer, 50 µM unlabeled dGTP, and 25 µCi of [alpha -32P]dTTP (3000 Ci/mmol). The reactions were stopped after 6 min, a time point within the linear range of DNA synthesis. The Km (for the primer) and Vmax values were determined by obtaining least square fitting lines of the data in Eadie-Hofstee plots and then calculating the inverse of the negative slope and x-intercept, respectively.

For determination of the processivity of substitution mutants, assays were performed using TEL66 as primer. The signal for each product was determined by PhosphorImager (Molecular Dynamics) and normalized to the amount of transcript by dividing against the number of labeled residues. The TEL66 primer ends in three Gs and can align to only one site along the yeast RNA template, thus supporting the addition of a defined sequence (TGTGGTG). The processivity for each position (Pi) was calculated using the formula Pi = sum(Ti+1 + Ti+2 +  ... + Tn)/sum(Ti + Ti+1 +  ... + Tn), where Ti designates the amount of transcript calculated for the primer + i position and n designates the highest number such that a visible signal can be discerned in the PhosphorImager file for the primer + n product.

Expression and Analysis of Recombinant CTE-- For expression of the TERT CTE, a PCR fragment encoding amino acids 747-874 of Est2p with flanking NdeI and XhoI sites was generated and cloned into the corresponding sites in pTYB12 (New England Biolabs). The resulting plasmid was transformed into BL21 cells. A transformant was inoculated into L broth and grown under ampicillin selection (50 µg/ml) at 37 °C overnight. A 10-ml culture of saturated cells was then diluted with 1 liter of L broth containing ampicillin and grown at 37 °C for 2.5 h. When the OD600 of the culture reached 0.5, the culture was cooled on ice for 30 min, induced by the addition of isopropyl-beta -D-thiogalactopyranoside to 0.1 mM, and grown at 17 °C for 16 h. The cells were harvested, and extracts were prepared by sonication. The CTE-containing fusion protein was bound to Chitin resin according to the manufacturer's instructions and then cleaved by incubating the resin in 50 mM dithiothreitol at room temperature for 16 h. The free CTE was eluted with 25 mM Tris·HCl, pH 8.0, 8 M urea and then was further enriched by either reverse phase HPLC or S-Sepharose. The HPLC purification was carried out on a Vydac C-4 preparative column (Hesperia, CA) using a water-acetonitrile gradient in the presence of 0.1% trifluoroacetic acid (37). The resulting preparation was lyophilized and solubilized in water. The S-Sepharose chromatography involved binding of free CTE to a column followed by elution with 25 mM Tris·HCl, pH 8.0, 8 M urea, 1 M NaCl. The resulting preparation was dialyzed stepwise into buffers containing lower concentrations of urea and NaCl until both were removed completely.

Circular dichroism (CD) spectra were acquired on an Aviv 62DS (Aviv Associates, Lakewood, NJ) CD spectropolarimeter equipped with a computer-controlled water bath using a thermostated cuvette of 0.1-cm path length. Measurements of [theta ]222 were performed at 0 °C in 50 mM sodium phosphate, pH 7.0, and 150 mM NaCl (37). Analytical ultracentrifugation measurements were carried out on a Beckman XL-A (Beckman Coulter) analytical ultracentrifuge using an An-60 Ti rotor (Beckman Coulter) (38). Filter-binding assays were carried out as described previously (33).

Determination of Telomere Length-- Chromosomal DNA was isolated using the "smash and grab" protocol, digested with PstI, and electrophoretically separated on a 1% agarose gel. Following capillary transfer to nylon membranes, telomere-containing fragments were detected by hybridization with a 32P-labeled poly(dG-dT) probe.

RNA and Protein Analysis-- The levels of Est2p-associated TLC1 RNA were determined by an RNase protection assay. IgG-Sepharose enriched telomerase was prepared as before and de-proteinated with SDS and proteinase K treatment and phenol extraction. The remaining nucleic acids were combined with an antisense probe (100,000 cpm) and hybridized and digested as described previously (39). For synthesis of uniformly labeled RNA probe, the TLC1 gene (nucleotides 1-1301) (40) was first amplified by PCR and cloned in between the BamHI and EcoRV site of pBluescript II KS+. The resulting plasmid was linearized by digestion with HinfI, and antisense RNA encompassing residues 1097-1301 of the TLC1 gene was generated by T3 RNA polymerase in the presence of 12 µM [alpha -32P]GTP as described (39). The levels of Est2p in cell extracts were determined by Western analysis as described previously (30).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Removal of the C-terminal Extension of TERT Causes a Reduction in the Stability of Telomerase-DNA Interaction-- To probe the function of the CTE, we generated a deletion mutant of Est2p (named C745) that removed most of the amino acids beyond the last conserved RT motif (Fig. 1A, motif E). A yeast strain harboring this deletion mutant was severely defective in telomere maintenance, and telomerase isolated from the strain exhibits a severe reduction in enzyme processivity (29). To further analyze the enzymatic defects associated with the removal of CTE, we measured the stability of telomerase-DNA binding using a primer-challenge assay. A test primer (TEL15(m12)) was pre-bound to either wild type or C745-containing telomerase followed by the addition of an excess of a competitor primer (TEL24). A labeled nucleotide was then added after various time intervals to initiate the extension reaction. The amounts of reaction products arising from the test primer were then quantified. As shown in Fig. 1, B and C, the challenge primer was able to reduce polymerization on the test primer more quickly when the C745 enzyme was used in the assays. Inspection of Fig. 1C indicates that the half-life of the telomerase-DNA complex for the TEL15(m12) primer was reduced by ~2-fold by the C-terminal truncation mutation (from about 2 to 1 min). These results are consistent with a role for CTE in telomerase-DNA interaction.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 1.   The C-terminal extension of Est2p enhances the stability of telomerase-DNA interaction. A, a schematic illustration of the structure of Est2p showing the locations of the conserved RT motifs, the N-terminal extension, and the C-terminal extension. B, wild type and C745 telomerase were subjected to the primer challenge protocol as described under "Materials and Methods." Products arising from extension of either TEL24 or TEL15(m12) are indicated by brackets to the left of the panel. The time intervals (in min) between the addition of the TEL24 primer and the nucleotides are indicated at the top. C, the signals for the test primer (TEL15(m12)) were normalized against the signal obtained in the absence of the challenge primer (TEL24) and plotted as a function of time.

We also measured the stability of telomerase-DNA binding after the primer has been extended. For this analysis, we took advantage of the stable association between protein A-tagged telomerase and IgG-Sepharose. Reactions were performed in duplicates using the TEL15(m12) primer. Upon termination of the reactions, the labeled products were separated into soluble and Sepharose-bound fractions before analysis in denaturing gels (Fig. 2A). The ratios of enzyme-bound products to free products at each extension position were then quantified. For ease of presentation, only the results for the Primer + 3 (p + 3) and Primer + 5 (p + 5) position are shown in Fig. 2B. At both positions, the C745 enzyme bound a smaller fraction of the reaction products than the wild type enzyme, consistent with impaired telomerase-DNA interaction. Similar results were obtained at other positions. It was also evident from the analysis that for both the wild type and C745 enzyme, the fraction of enzyme-bound products was higher at the p + 5 than at the p + 3 position, consistent with the ability of a longer RNA-DNA hybrid to promote enzyme-DNA stability.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 2.   The C745 telomerase binds less stably to its extension products. A, duplicate primer extension assays were carried out using a telomeric oligonucleotide, [32P]dGTP, dTTP, and either wild type or C745 telomerase. Upon termination, the products were separated into free (Free) and enzyme-bound (Bound) fractions and analyzed by a denaturing gel. The location of the primer + 3 (+3) product is marked by horizontal lines to the left and right of the panel. B, the ratios of enzyme-bound to free product for the primer + 3 (p + 3) and primer + 5 (p + 5) products synthesized by both the wild type and C745 enzyme are plotted.

As yet another measure of telomerase-DNA interaction, we carried out kinetic analysis of nucleotide addition for both the wild type and mutant enzyme. Assays were performed using varying concentrations of a primer oligonucleotide, and the results were analyzed by Eadie-Hofstee plots. As shown in Fig. 3, A and B, the Km for the C745 telomerase was ~2.5-fold higher than that for the wild type enzyme, consistent with reduced binding of the primer to the truncated telomerase. Thus, by three different criteria, the loss of the CTE of yeast TERT resulted in a telomerase that binds less strongly to telomeric DNA.


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 3.   The C745 telomerase exhibits an increased Km for a telomeric primer. A, primer extension assays were carried out using varying concentrations of a telomeric primer (0.17, 0.34, 0.67, 1.3, and 2.6 µM) and either wild type or C745 telomerase. Reactions were terminated at 6 min (a time point within the linear range of product accumulation), and the products were analyzed by a denaturing gel. B, Eadie-Hofstee plots of the results obtained for the wild type and C745 telomerase. The derived Km and Vmax values for both enzymes are listed at the right.

The C-terminal Extension of TERT Can Bind Nucleic Acids-- To determine whether the CTE of TERT can indeed bind nucleic acids as would be expected for the thumb domain, we expressed amino acids 747-874 of yeast TERT as a fusion protein to an intein-CBD (chitin-binding domain) tag. The fusion protein was purified by adsorption to a chitin column, and the CTE was separated from the tag by intein-mediated self-cleavage in the presence of dithiothreitol. For unknown reasons, the CTE fragment remained bound to the column after cleavage and could not be eluted even with high salt. We therefore eluted the CTE fragment with urea. Following elution, the CTE was purified further either with a reverse phase HPLC or an S-Sepharose column. The HPLC preparation was lyophilized and solubilized in water, whereas the S-Sepharose preparation was renatured by stepwise dialysis into buffers containing reducing concentrations of urea. As shown in Fig. 4A, both preparations are nearly homogeneous. We then subjected the HPLC-purified fragment to analytical ultracentrifugation and CD analysis. These studies revealed a monomeric protein with high alpha -helical content (data not shown). Thus, despite the denaturation step during isolation, the purified CTE appears to be well folded.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 4.   The CTE of Est2p possesses a nucleic acid binding activity. A, the CTE purified by either an S or HPLC column was analyzed by SDS-PAGE and stained with Coomassie Brilliant Blue. B, the CTE (purified by an S column) and Maltose-binding protein (MBP) were tested for binding to 1 nM of a single-stranded telomeric oligonucleotide (TGTGTGGGTGTGTGGGTGTGTGGG), and the results were plotted. C, the CTE (purified by an S column, 4 µg) was tested for binding to 1 nM of three different substrates. The single strand DNA is a 15-mer oligonucleotide with a telomere-like sequence (TGTGTGGTGTGTGGG). The double strand DNA and RNA-DNA hybrid were generated by annealing the same oligonucleotide to fully complementary DNA and RNA oligomers, respectively. The background was subtracted from the signals and the results plotted.

The purified CTE was tested for its ability to interact with nucleic acids using a nitrocellulose filter-binding assay. First, a single-stranded 24-mer oligonucleotide with a telomere-like sequence was assessed for binding. As shown in Fig. 4B, the S-Sepharose-purified CTE exhibited concentration-dependent binding to this oligonucleotide, whereas a control protein (maltose-binding protein) did not. We then compared the ability of single-stranded DNA, double-stranded DNA, and RNA-DNA hybrid (all with telomere-like sequences) to bind CTE. Equal molar concentrations of the different substrates were tested in filter-binding assays using the same amount of CTE. Interestingly, as shown in Fig. 4C, CTE appears to manifest a slight preference for double-stranded substrates (~2-3-fold), consistent with its putative role in contacting an RNA-DNA hybrid in the context of a telomerase-DNA complex. Analysis of nucleic acid binding by the HPLC-purified CTE gave comparable results (data not shown).

Conserved Residues in the CTE of Yeast TERT Are Required for Telomerase Activity and Processivity-- Even though the CTEs of TERTs do not exhibit significant sequence similarity to retroviral RTs, they appear to be loosely conserved as a group (29). To determine whether the sequence conservation has functional significance, we mutated conserved residues within the CTE of yeast TERT and tested the resulting enzyme for defects both in vivo and in vitro. A total of five mutants with substitutions in conserved residues (SCR mutants) were made, each with two or three consecutive residues changed to alanines: LF759AA, TID768AAA, NS774AA, YK794AA, FL847AA (with the number designating the position of the first amino acid residue in each pair or triplet; Fig. 5A). For comparison, a mutant with substitutions in non-conserved residues was also made (CD831AA). Each mutant was tagged at the C terminus with tandem copies of the IgG-binding domain of proteins A, placed on a centromeric plasmid, and used to transform a yeast strain whose chromosomal EST2 (TERT) gene has been disrupted. A similarly tagged wild type EST2 gene was analyzed in parallel as the control.


View larger version (42K):
[in this window]
[in a new window]
 
Fig. 5.   Conserved residues in the CTE of Est2p are required for telomere maintenance. A, a schematic illustration of the CTE of Est2p showing conserved regions and the residues chosen for mutagenesis. There are apparently two moderately conserved blocks as indicated by gray bars. The locations of five mutants with substitutions in conserved residues are indicated by filled boxes, and that of the single mutant with substitutions in non-conserved residues is indicated by an open box. For a detailed alignment of CTEs see Ref. 29. B, telomere lengths were determined for strains bearing either wild type or mutated Est2ps. The identities of the Est2ps in the strains are indicated at the top of the panel. The locations of the Y'-type telomeres and an X-type telomere are indicated by brackets to the left of the panel.

All of the strains were first tested for telomere length defects. As shown in Fig. 5B, all five SCR mutants exhibited varying degrees of telomere shortening, whereas the CD831AA mutant did not. The most defective SCR mutants (TID768AA, NS774AA, and YK794AA) have telomeres that are indistinguishable from the C745 truncation mutant, suggesting that these substitutions have completely abolished the function of CTE in vivo.

To determine whether the telomere maintenance defects can be explained by telomerase activity loss or alteration, we purified protein A-tagged telomerase from the wild type and mutant strains by IgG-Sepharose and subjected it to primer extension assays (Fig. 6A). The results were analyzed both in terms of the overall levels of DNA synthesis (Fig. 6B) and the processivity of nucleotide addition (Fig. 6C). As expected, the CD831AA mutant exhibited a nearly normal level of telomerase activity and a normal pattern of extension, consistent with its ability to maintain normal telomere lengths. In contrast, all of the SRC mutants suffered either a loss of total activity, a significant reduction in enzyme processivity, or both. Interestingly, the two mutants with total activity loss but no evident processivity defect (LF759AA and FL847AA) manifested relatively modest telomere shortening such that the levels of activity correlated with the lengths of telomeres. On the other hand, the three mutants with substantial processivity defects (TID768AAA, NS774AA, and YK794AA) all manifested severe telomere shortening. Of the three, only the YK794AA mutant suffered substantial loss of total activity (>10-fold). These results are in accordance with earlier studies and indicate that both the total activity and the processivity of telomerase are important determinants of telomere lengths. Processivity appears to be the more dominant factor, because only a modest reduction in processivity was sufficient to trigger severe telomere shortening (29).


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 6.   Conserved residues in the CTE of Est2p are required for either telomerase activity or processivity. A, telomerase from the wild type and various mutant strains was isolated by IgG affinity chromatography and tested in primer extension assays using TEL66 primer, [32P]dGTP, and dTTP. The identities of the mutations are indicated at the top, and the location of the primer + 3 (+3) product is indicated by a horizontal line at the left. An RNase-insensitive band (indicated by an asterisk) can sometimes be observed in these assays, presumably because of a contaminating activity. B, total DNA synthesis mediated by the mutant enzymes was determined in duplicate assays and normalized against that by the wild type enzyme, and the results were plotted. C, the processivity of the wild type and mutant enzymes for the primer + 3 (+3) and the primer + 4 (+4) positions were determined in duplicate assays, and the results were plotted.

The substantial loss of overall activity exhibited by the YK794AA and the FL847AA mutants are surprising in light of previous analysis of the C745 truncation mutant, which has no CTE yet suffers only a modest reduction in overall activity. To determine the basis for the activity loss manifested by the substitutions mutants, we quantified the levels of Est2p and Est2p-associated TLC1 RNA (yeast telomerase RNA) in wild type and mutant strains. As shown in Fig. 7, A and B, both the YK794AA and FL847AA mutants have much lower levels of Est2p and Est2p-associated TLC1 RNA in cell extracts, whereas the other mutants have very few defects in this regard. Quantitation indicates that the magnitude of reduction for both RNA and protein was ~4-10-fold (data not shown). These results suggest that substitution in some conserved CTE residues can impair protein stability (possibly by causing protein misfolding), thereby leading to a reduction in the level of telomerase ribonucleoprotein.


View larger version (45K):
[in this window]
[in a new window]
 
Fig. 7.   Two mutations in CTE significantly reduced the levels of Est2p and Est2p-associated telomerase RNA. A, levels of protein A-tagged Est2p in the wild type and mutant strains were determined by Western-blotting using antibodies directed against protein A. B, the levels of Est2p-associated TLC1 RNA in the wild type and mutant strains were determined by RNase protection assays. The position of the protected TLC1 fragment is indicated by an arrow on the right.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The Function of the C-terminal Extension of Telomerase Reverse Transcriptase-- We have shown in this and an earlier study (29) that the CTE of yeast TERT is required for optimal telomerase processivity and stable telomerase-DNA binding. The yeast CTE also possesses a nucleic acid binding activity when recombinantly overexpressed and purified. These results support the notion that despite the lack of sequence similarity between CTE and the thumb domain of conventional RTs, the CTE of TERT may nevertheless act as a thumb for telomerase.

A precedent for sequence divergence coupled with functional (and potential structural) similarity was noted in structural comparison of the thumbs of HIV-1 RT and HCV RNA-dependent RNA polymerase (41). Although both thumbs are believed to contact and help encircle the nucleic acids, they do not show significant sequence homology. Structurally, the HCV domain is much larger with seven instead of three helices. Nevertheless, a modeling exercise suggests that one of the HCV thumb helices (helix P) may have the same disposition relative to nucleic acids as an HIV-1 helix (helix H), which has been shown to be important for substrate interactions (41, 42). Results of our CD analysis provide tantalizing support for the existence of a comparable helix in the CTE of TERTs. Clearly, high-resolution structural analysis of CTE will be required to address this possibility.

Telomerase from several species has been shown to form dimers/multimers in vitro and in vivo, although the subunit or domain of the complex responsible for dimerization is not well characterized. The functional significance of dimerization also remains to be determined. The monomeric behavior of the yeast CTE in solution suggests that this domain cannot be the sole determinant of dimerization. This is in agreement with a recent analysis of hTERT, which also fails to detect a homotypic interaction of its CTE domain (43).

Potential Sequence and Functional Conservation among the CTEs of TERTs-- Deletion analysis of CTE in different organisms yielded somewhat disparate results. Removal of part or all of the CTE of the Tetrahymena and human TERT was found to result in a completely inactive telomerase in either in vitro or in vivo reconstitution assays (44-46). In contrast, as we have demonstrated in this and an earlier study, removal of the entire CTE of yeast TERT resulted in a catalytically active telomerase with greatly reduced processivity (29). This discrepancy raises the possibility that the CTEs of different TERTs may perform fundamentally different functions. However, this possibility would appear to be contradicted by our mutagenesis studies, which indicate that conserved CTE residues identified by sequence alignment are indeed functionally important, either for protein stability or telomerase processivity.

How might the different deletion analysis results be reconciled? Two hypotheses may be considered. First, we have shown that several partial deletions of yeast CTE and amino acid substitution of conserved CTE residues can lead to greatly diminished TERT levels in cell extracts, suggesting that these mutations cause protein misfolding and destabilization (29). It is possible that partial deletions of the Tetrahymena and human CTE can have similar deleterious effects. Second, the nucleic acid binding function of the CTE may be more or less essential for telomerase activity, depending on the presence of other nucleic acid binding modules/domains in the enzyme complex. For example, the yeast telomerase reconstituted in vivo may possess other nucleic acid binding components that can partially compensate for the loss of CTE. In this regard, it is interesting to note that Est1p, a non-catalytic component of yeast telomerase, has been shown to possess a single-stranded telomeric DNA binding activity (47, 48). Another distinguishing feature of the yeast enzyme is its relatively long RNA template (17 nucleotides instead of 9 or 10 nucleotides for the Tetrahymena and human RNA), which can presumably bind more strongly to the DNA primer and possibly alleviate the consequence of CTE loss.

Although our evidence favors at least one conserved function for CTE, it by no means rules out some additional species-specific functions such as interaction with other components of the telomerase holoenzyme. In particular, the addition of an epitope tag to the C terminus of hTERT resulted in a catalytically active telomerase that is unable to maintain telomeres in vivo, a finding that argues for just such a species-specific function (49).

    ACKNOWLEDGEMENTS

We thank Dr. Min Lu for the CD and equilibrium centrifugation analysis and members of the Lue lab for reading and commenting on the manuscript.

    FOOTNOTES

* This work was supported by an American Cancer Society research project grant, the Tartikoff/Perelman/EIF Fund from the Academic Medicine Development Company, and an RO1 grant from the National Institutes of Health. The Department of Microbiology and Immunology was supported by the William Randolph Hearst Foundation.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel.: 212-746-6506; Fax: 212-746-8587; E-mail: nflue@mail.med.cornell.edu.

Published, JBC Papers in Press, July 31, 2002, DOI 10.1074/jbc.M201976200

    ABBREVIATIONS

The abbreviations used are: RT, reverse transcriptase; CTE, C-terminal extension; HPLC, high pressure liquid chromatography; CD, circular dichroism; SCR, substitutions in conserved residues; TERT, telomerase reverse transcriptase.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Greider, C. W., and Blackburn, E. H. (1985) Cell 43, 405-413[CrossRef][Medline] [Order article via Infotrieve]
2. Greider, C. W., and Blackburn, E. H. (1989) Nature 337, 331-337[CrossRef][Medline] [Order article via Infotrieve]
3. Blackburn, E. H. (1992) Ann. Rev. Biochem. 61, 113-129[CrossRef][Medline] [Order article via Infotrieve]
4. Nugent, C. I., and Lundblad, V. (1998) Genes Dev. 12, 1073-1085[Free Full Text]
5. Tzfati, Y., Fulton, T. B., Roy, J., and Blackburn, E. H. (2000) Science 288, 863-867[Abstract/Free Full Text]
6. Chen, J. L., Blasco, M. A., and Greider, C. W. (2000) Cell 100, 503-514[CrossRef][Medline] [Order article via Infotrieve]
7. Lendvay, T. S., Morris, D. K., Sah, J., Balasubramanian, B., and Lundblad, V. (1996) Genetics 144, 1399-1412[Abstract]
8. Lingner, J., and Cech, T. R. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 10712-10717[Abstract/Free Full Text]
9. Lingner, J., Hughes, T. R., Shevchenko, A., Mann, M., Lundblad, V., and Cech, T. R. (1997) Science 276, 561-567[Abstract/Free Full Text]
10. Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., and Cech, T. R. (1997) Science 277, 955-959[Abstract/Free Full Text]
11. Meyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddle, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoof, M. J., Liu, Q., Bacchetti, S., Haber, D. A., and Weinberg, R. A. (1997) Cell 90, 785-795[CrossRef][Medline] [Order article via Infotrieve]
12. Kilian, A., Bowtell, D. D., Abud, H. E., Hime, G. R., Venter, D. J., Keese, P. K., Duncan, E. R., Reddel, R. R., and Jefferson, R. A. (1997) Hum. Mol. Genet. 6, 2011-2019[Abstract/Free Full Text]
13. Bryan, T. M., Sperger, J. M., Chapman, K. B., and Cech, T. R. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 8479-8484[Abstract/Free Full Text]
14. Collins, K., and Gandhi, L. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 8485-8490[Abstract/Free Full Text]
15. Greenberg, R. A., Allsopp, R. C., Chin, L., Morin, G. B., and DePinho, R. A. (1998) Oncogene 16, 1723-1730[CrossRef][Medline] [Order article via Infotrieve]
16. Oguchi, K., Liu, H., Tamura, K., and Takahashi, H. (1999) FEBS Lett. 457, 465-469[CrossRef][Medline] [Order article via Infotrieve]
17. Fitzgerald, M. S., Riha, K., Gao, F., Ren, S., McKnight, T. D., and Shippen, D. E. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 14813-14818[Abstract/Free Full Text]
18. Weinrich, S. L., Pruzan, R., Ma, L., Ouellette, M., Tesmer, V. M., Holt, S. E., Bodnar, A. G., Lichtsteiner, S., Kim, N. W., Trager, J. B., Taylor, R. D., Carlos, R., Andrews, W. H., Wright, W. E., Shay, J. W., Harley, C. B., and Morin, G. B. (1997) Nat. Genet. 17, 198-502[CrossRef][Medline] [Order article via Infotrieve]
19. Beattie, T. L., Zhou, W., Robinson, M. O., and Harrington, L. (1998) Curr. Biol. 8, 177-180[CrossRef][Medline] [Order article via Infotrieve]
20. Collins, K., Kobayashi, R., and Greider, C. W. (1995) Cell 81, 677-686[CrossRef][Medline] [Order article via Infotrieve]
21. Gandhi, L., and Collins, K. (1998) Genes Dev. 12, 721-733[Abstract/Free Full Text]
22. Harrington, L., McPhail, T., Mar, V., Zhou, W., Oulton, R., Program, A. E., Bass, M. B., Arruda, I., and Robinson, M. O. (1997) Science 275, 973-977[Abstract/Free Full Text]
23. Nakayama, J.-I., Saito, M., Nakamura, H., Matsuura, A., and Ishikawa, F. (1997) Cell 88, 875-884[CrossRef][Medline] [Order article via Infotrieve]
24. Holt, S. E., Aisner, D. L., Baur, J., Tesmer, V. M., Dy, M., Ouellette, M., Trager, J. B., Morin, G. B., Toft, D. O., Shay, J. W., Wright, W. E., and White, M. A. (1999) Genes Dev. 13, 817-826[Abstract/Free Full Text]
25. Counter, C. M., Meyerson, M., Eaton, E. N., and Weinberg, R. A. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 9202-9207[Abstract/Free Full Text]
26. Harrington, L., Zhou, W., McPhail, T., Oulton, R., Yeung, D. S. K., Mar, V., Bass, M. B., and Robinson, M. O. (1997) Genes Dev. 11, 3109-3115[Abstract/Free Full Text]
27. Haering, C. H., Nakamura, T. M., Baumann, P., and Cech, T. R. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 6367-6372[Abstract/Free Full Text]
28. Bryan, T. M., Goodrich, K. J., and Cech, T. R. (2000) J. Biol. Chem. 275, 24199-24207[Abstract/Free Full Text]
29. Peng, Y., Mian, I. S., and Lue, N. F. (2001) Mol. Cell 7, 1201-1211[CrossRef][Medline] [Order article via Infotrieve]
30. Bosoy, D., and Lue, N. (2001) J. Biol. Chem. 276, 46305-46312[Abstract/Free Full Text]
31. Miller, M. C., Liu, J. K., and Collins, K. (2000) EMBO J. 19, 4412-4422[CrossRef][Medline] [Order article via Infotrieve]
32. Huang, H., Chopra, R., Verdine, G. L., and Harrison, S. C. (1998) Science 282, 1669-1675[Abstract/Free Full Text]
33. Xia, J., Peng, Y., Mian, I. S., and Lue, N. F. (2000) Mol. Cell. Biol. 20, 5196-5207[Abstract/Free Full Text]
34. Cohn, M., and Blackburn, E. H. (1995) Science 269, 396-400[Abstract/Free Full Text]
35. Lue, N. F., and Peng, Y. (1998) Nucleic Acids Res. 26, 1487-1494[Abstract/Free Full Text]
36. Lue, N. F., and Xia, J. (1998) Nucleic Acids Res. 26, 1495-1502[Abstract/Free Full Text]
37. Shu, W., Ji, H., and Lu, M. (1999) Biochemistry 38, 5378-5385[CrossRef][Medline] [Order article via Infotrieve]
38. Laue, T. M., Shah, B. D., Ridgeway, T. M., and Pelletier, S. L. (1992) in Analytical Ultracentrifugation in Biochemistry and Polymer Science. (Harding, S. E. , Rowe, A. J. , and Horton, J. C., eds) , pp. 90-125, Royal Society of Chemistry, Cambridge
39. Lue, N. F., and Kornberg, R. D. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 8839-8843[Abstract/Free Full Text]
40. Singer, M. S., and Gottschling, D. E. (1994) Science 266, 404-409[Abstract/Free Full Text]
41. Bressanelli, S., Tomei, L., Roussel, A., Incitti, I., Vitale, R., Mathieu, M., De, F. R., and Rey, F. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 13034-13039[Abstract/Free Full Text]
42. Bebenek, K., Beard, W. A., Casas-Finet, J. R., Kim, H. R., Darden, T. A., Wilson, S. H., and Kunkel, T. A. (1995) J. Biol. Chem. 270, 19516-19523[Abstract/Free Full Text]
43. Arai, K., Masutomi, K., Khurts, S., Kaneko, S., Kobayashi, K., and Murakami, S. (2002) J. Biol. Chem., in press
44. Bachand, F., and Autexier, C. (2001) Mol. Cell. Biol. 21, 1888-1897[Abstract/Free Full Text]
45. Lai, C. K., Mitchell, J. R., and Collins, K. (2001) Mol. Cell. Biol. 21, 990-1000[Abstract/Free Full Text]
46. Beattie, T. L., Zhou, W., Robinson, M. O., and Harrington, L. (2000) Mol. Biol. Cell 11, 3329-3340[Abstract/Free Full Text]
47. Virta-Pearlman, V., Morris, D. K., and Lundblad, V. (1996) Genes Dev. 10, 3094-3104[Abstract/Free Full Text]
48. Zhou, J., Hidaka, K., and Futcher, B. (2000) Mol. Cell. Biol. 20, 1947-1955[Abstract/Free Full Text]
49. Counter, C. M., Hahn, W. C., Wei, W., Caddle, S. D., Beijersbergen, R. L., Lansdorp, P. M., Sedivy, J. M., and Weinberg, R. A. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 14723-14728[Abstract/Free Full Text]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
S. N. Finger and T. M. Bryan
Multiple DNA-binding sites in Tetrahymena telomerase
Nucleic Acids Res., March 27, 2008; 36(4): 1260 - 1272.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H. D. M. Wyatt, D. A. Lobb, and T. L. Beattie
Characterization of Physical and Functional Anchor Site Interactions in Human Telomerase
Mol. Cell. Biol., April 15, 2007; 27(8): 3226 - 3240.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Z.-T. Xin, A. D. Beauchamp, R. T. Calado, J. W. Bradford, J. A. Regal, A. Shenoy, Y. Liang, P. M. Lansdorp, N. S. Young, and H. Ly
Functional characterization of natural telomerase mutations found in patients with hematologic disorders
Blood, January 15, 2007; 109(2): 524 - 532.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
E. J. Middleman, J. Choi, A. S. Venteicher, P. Cheung, and S. E. Artandi
Regulation of Cellular Immortalization and Steady-State Levels of the Telomerase Reverse Transcriptase through Its Carboxy-Terminal Domain.
Mol. Cell. Biol., March 1, 2006; 26(6): 2146 - 2159.
[Abstract] [Full Text] [PDF]


Home page
RNAHome page
T. J. MORIARTY, D. T. MARIE-EGYPTIENNE, and C. AUTEXIER
Regulation of 5' template usage and incorporation of noncognate nucleotides by human telomerase
RNA, September 1, 2005; 11(9): 1448 - 1460.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. F. Lue
A Physical and Functional Constituent of Telomerase Anchor Site
J. Biol. Chem., July 15, 2005; 280(28): 26586 - 26591.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
T. J. Moriarty, R. J. Ward, M. A.S. Taboski, and C. Autexier
An Anchor Site-Type Defect in Human Telomerase That Disrupts Telomere Length Maintenance and Cellular Immortalization
Mol. Biol. Cell, July 1, 2005; 16(7): 3152 - 3161.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. J. Moriarty, D. T. Marie-Egyptienne, and C. Autexier
Functional Organization of Repeat Addition Processivity and DNA Synthesis Determinants in the Human Telomerase Multimer
Mol. Cell. Biol., May 1, 2004; 24(9): 3720 - 3733.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
D. Bosoy and N. F. Lue
Yeast telomerase is capable of limited repeat addition processivity
Nucleic Acids Res., January 2, 2004; 32(1): 93 - 101.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
N. F. Lue, Y.-C. Lin, and I. S. Mian
A Conserved Telomerase Motif within the Catalytic Domain of Telomerase Reverse Transcriptase Is Specifically Required for Repeat Addition Processivity
Mol. Cell. Biol., December 1, 2003; 23(23): 8440 - 8449.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. Huard, T. J. Moriarty, and C. Autexier
The C terminus of the human telomerase reverse transcriptase is a determinant of enzyme processivity
Nucleic Acids Res., July 15, 2003; 31(14): 4059 - 4070.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. M. Singh and N. F. Lue
Ever shorter telomere 1 (EST1)-dependent reverse transcription by Candida telomerase in vitro: Evidence in support of an activating function
PNAS, May 13, 2003; 100(10): 5718 - 5723.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/39/36174    most recent
M201976200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Ar